Page last updated: 2024-12-06

pipazethate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pipazethate is a synthetic, non-selective dopamine receptor antagonist. It is a relatively potent antagonist at D1, D2, D3, and D4 receptors, with an affinity for D2 receptors being slightly greater than that for D1 receptors. The drug is of interest due to its ability to improve cognitive function in patients with Alzheimer's disease and other cognitive disorders. It is also being investigated for its potential to treat addiction, Parkinson's disease, and Huntington's disease. Pipazethate has been shown to improve memory and attention in animal models of Alzheimer's disease. However, there is no current clinical evidence to support the use of pipazethate for the treatment of Alzheimer's disease or other cognitive disorders. It is important to note that pipazethate has not been approved for use in the United States and is currently only available for research purposes.'

pipazethate: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID22425
CHEMBL ID2104900
CHEBI ID135635
SCHEMBL ID149990
MeSH IDM0065813

Synonyms (53)

Synonym
theratuss
d 254
10h-pyrido(3,2-b)(1,4)benzothiazine-10-carboxylic acid, 2-(2-piperidinoethoxy)ethyl ester
einecs 218-508-8
pipazethate
2-(2-piperidinoethoxy)ethyl 10h-pyrido(3,2-b)(1,4)benzothiazine-10-carboxylate
pipazetatum [inn-latin]
pipazetato [inn-spanish]
lenopect
brn 1091957
skf 70230 a
sq 15874
pipazetate
10h-pyrido(3,2-b)(1,4)benzothiazine-10-carboxylic acid, 2-(2-(1-piperidinyl)ethoxy)ethyl ester
pipazetate (inn)
pipazethate (usan)
2167-85-3
D05484
CHEBI:135635
DB08796
2-(2-piperidin-1-ylethoxy)ethyl pyrido[3,2-b][1,4]benzothiazine-10-carboxylate
pipazethate [usan]
m5ek1t5v2l ,
d-254
sk&f 70230-a
pipazetate [inn]
sq 15,874
pipazetatum
pipazetato
unii-m5ek1t5v2l
sq-15874
so 15,874
CHEMBL2104900
SCHEMBL149990
pipazetate [who-dd]
2-(2-piperidinoethoxy)ethyl 10h-pyrido[3,2-b][1,4]benzothiazine-10-carboxylate
pipazethate [mi]
sk&f-70230-a
pipazetate [mart.]
2-(2-piperidinoethoxy)ethyl 10h-pyrido[3,2-b][1,4]benzothiadiazine-10-carboxylate
10h-pyrido[3,2-b][1,4]benzothiazine-10-carboxylic acid, 2-(2-piperidinoethoxy)ethyl ester
skf 70230-a
DTVJXCOMJLLMAK-UHFFFAOYSA-N
10h-pyrido[3,2-b][1,4]benzothiazine-10-carboxylic acid, 2-[2-(1-piperidinyl)ethoxy]ethyl ester
2-[2-(1-piperidinyl)ethoxy]ethyl 10h-pyrido[3,2-b][1,4]benzothiazine-10-carboxylate #
DTXSID40176056
2-[2-(piperidin-1-yl)ethoxy]ethyl 9-thia-2,4-diazatricyclo[8.4.0.0^{3,8}]tetradeca-1(10),3,5,7,11,13-hexaene-2-carboxylate
pipazetat
Q7197205
skf 70230a; sq 15874;d 254;pipazetate
CS-0017506
HY-B2090
AKOS040753563

Research Excerpts

Dosage Studied

The developed methods were validated in accordance with ICH guidelines. They successfully applied to the analysis of pipazethate HCl in dosage forms with good accuracy and precision.

ExcerptRelevanceReference
"Three simple, sensitive, precise, reproducible and validated spectrophotometric methods have been developed for the quantification of pipazethate HCl as antitussive drug in pure and dosage forms."( Utilization of N-bromosuccinimide for the sensitive spectrophotometric determination of pipazethate HCl as antitussive drug in pure and dosage forms.
Abourehab, MAS; Ellateif, A; Fawzi, SM; Gouda, AA; Shahin, MHK; Sheikh, RE, 2021
)
1.05
"The developed methods were validated in accordance with ICH guidelines and successfully applied to the analysis of pipazethate HCl in dosage forms with good accuracy and precision."( Utilization of N-bromosuccinimide for the sensitive spectrophotometric determination of pipazethate HCl as antitussive drug in pure and dosage forms.
Abourehab, MAS; Ellateif, A; Fawzi, SM; Gouda, AA; Shahin, MHK; Sheikh, RE, 2021
)
1.05
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aryl sulfideAny organic sulfide in which the sulfur is attached to at least one aromatic group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (60.00)18.7374
1990's1 (6.67)18.2507
2000's4 (26.67)29.6817
2010's0 (0.00)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.06 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index55.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (17.65%)4.05%
Observational0 (0.00%)0.25%
Other14 (82.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]